Compare AU
Compare ILC vs. EDOC
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the S&P/ASX Aussie 20 Large Caps (ILC) and the BetaShares Digital Health and Telemedicine ETF (EDOC). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
ILC | EDOC | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 36 | 10 |
Median incremental investment | $920.36 | $705.01 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,786.17 | $624.97 |
Average age group | > 35 | > 35 |
Key Summary
ILC | EDOC | |
|---|---|---|
Strategy | ILC.AX was created on 2010-12-06 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 664.02m in AUM and 21 holdings. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of the 20 largest Australian securities listed on the ASX. | EDOC.AX was created on 2022-03-30 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. The investment objective of the BetaShares Digital Health and Telemedicine ETF is to provide an investment return that aims to track the performance of the NASDAQ CTA Global Digital Health Index (the Index), before taking into account fees and expenses. |
Top 3 holdings | COMMONWEALTH BANK OF AUSTRALIA (15.55 %) BHP GROUP LTD (13.88 %) CSL LTD (9.45 %) | INSULET CORP (8.47 %) BOSTON SCIENTIFIC CORP (8.24 %) ABBOTT LABORATORIES (7.76 %) |
Top 3 industries | Financials (44.02 %) Materials (20.36 %) Health Care (9.45 %) | Health Care (75.06 %) Other (24.70 %) Consumer Staples (14.33 %) |
Top 3 countries | Australia (98.61 %) United States (1.39 %) | United States (77.51 %) China (13.32 %) Japan (4.67 %) |
Management fee | 0.24 % | 0.67 % |
Key Summary
ILC | EDOC | |
|---|---|---|
Issuer | iShares | BetaShares |
Tracking index | S&P/ASX 20 - AUD | Nasdaq CTA Global Digital Health Index - AUD - Benchmark TR Net |
Asset class | ETF | ETF |
Management fee | 0.24 % | 0.67 % |
Price | $32.17 | $10.33 |
Size | $687.198 million | $1.525 million |
10Y return | 34.43 % | N/A |
Annual distribution yield (5Y) | 6.44 % | - % |
Market | ASX | ASX |
First listed date | 09/12/2010 | 29/03/2022 |
Purchase fee | $6.50 | $6.50 |
Community Stats
ILC | EDOC | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 36 | 10 |
Median incremental investment | $920.36 | $705.01 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,786.17 | $624.97 |
Average age group | > 35 | > 35 |
Pros and Cons
ILC | EDOC | |
|---|---|---|
Pros |
|
|
Cons |
|
|
ILC | EDOC |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |